On November 6, 2025, Nurix Therapeutics, Inc. appointed Dr. Roger Dansey as a director, granting him 50,000 stock options and annual retainers amounting to $50,000 and $7,500 for board and committee service respectively. This event is significant for the company and carries a positive sentiment.